Go Pro

908 Devices (MASS) Institutional Ownership

908 Devices logo
$8.92 +0.04 (+0.43%)
As of 12:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for 908 Devices (NASDAQ:MASS)

Current
Institutional Ownership
Percentage
88.06%
Number of
Institutional Buyers
(last 12 months)
56
Total
Institutional Inflows
(last 12 months)
$91.11M
Number of
Institutional Sellers
(last 12 months)
29
Total
Institutional Outflows
(last 12 months)
$39.45M
Get MASS Insider Trade Alerts

Want to know when executives and insiders are buying or selling 908 Devices stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

MASS Institutional Buying and Selling by Quarter

908 Devices Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/7/2026 BlackRock Inc.1,944,236$16.92M0.0%N/A5.142%
8/7/2026 Deutsche Bank AG28,412$247K0.0%N/A0.075%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.110,557$962K0.0%N/A0.292%
8/6/2026 Bank of New York Mellon Corp72,758$633K0.0%N/A0.192%
8/6/2026 GSA Capital Partners LLP49,160$428K0.0%N/A0.130%
5/16/2026First Light Asset Management LLC6,072,563$37.16M3.3%+25.6%16.061%
5/15/2026 Intelligence Driven Advisers LLC10,000$61K0.0%N/A0.026%
5/15/2026Granahan Investment Management LLC695,070$4.25M0.2%+662.6%1.838%
5/14/2026Renaissance Technologies LLC230,200$1.41M0.0%+3.6%0.609%
5/14/2026Sei Investments Co.164,894$1.01M0.0%+101.2%0.436%
5/8/2026Amova Asset Management Americas Inc.269,873$1.65M0.0%-6.3%0.721%
5/7/2026Dimensional Fund Advisors LP118,751$726K0.0%-51.8%0.317%
5/5/2026 Bank of New York Mellon Corp59,041$361K0.0%-3.2%0.158%
4/30/2026 Sumitomo Mitsui Trust Group Inc.269,873$1.65M0.0%-6.3%0.722%
4/28/2026GM Advisory Group LLC238,218$1.46M0.1%-14.6%0.637%
2/18/2026XTX Topco Ltd19,852$104K0.0%-55.9%0.055%
2/18/2026Millennium Management LLC158,103$830K0.0%+409.0%0.437%
2/18/2026Engineers Gate Manager LP26,681$140K0.0%N/A0.074%
2/18/2026Bridgeway Capital Management LLC50,500$265K0.0%+65.6%0.140%
2/17/2026First Light Asset Management LLC4,836,186$25.39M1.9%+92.6%13.363%
2/17/2026State of Wisconsin Investment Board32,294$170K0.0%N/A0.089%
2/17/2026Granahan Investment Management LLC91,141$478K0.0%+41.7%0.252%
2/17/2026Graham Capital Management L.P.20,787$109K0.0%+12.9%0.057%
2/17/2026 Opal Capital LLC17,581$92K0.0%N/A0.049%
2/17/2026Meros Investment Management LP347,035$1.82M0.7%+232.7%0.959%
2/17/2026Needham Investment Management LLC770,000$4.04M0.3%+246.8%2.128%
2/16/2026Squarepoint Ops LLC218,676$1.15M0.0%+63.5%0.604%
2/16/2026Barclays PLC44,528$234K0.0%+15.4%0.123%
2/13/2026Marshall Wace LLP190,635$1.00M0.0%-56.6%0.527%
2/13/2026GM Advisory Group LLC278,792$1.46M0.1%-58.9%0.770%
2/13/2026PCM Encore LLC11,830$62K0.0%N/A0.033%
2/13/2026 Essex Investment Management Co. LLC482,614$2.53M0.4%-2.3%1.334%
2/13/2026 State Street Corp596,294$3.13M0.0%-74.1%1.648%
2/13/2026Wells Fargo & Company MN30,623$161K0.0%+72.1%0.085%
2/12/2026Jane Street Group LLC36,795$193K0.0%N/A0.102%
2/12/2026HRT Financial LP154,830$812K0.0%N/A0.428%
2/12/2026Renaissance Technologies LLC222,100$1.17M0.0%+6.1%0.614%
2/12/2026Dimensional Fund Advisors LP246,614$1.30M0.0%-24.1%0.681%
2/12/2026 IQ EQ FUND MANAGEMENT IRELAND Ltd78,026$410K0.0%+47.8%0.216%
2/12/2026 Campbell & CO Investment Adviser LLC80,553$423K0.0%+21.2%0.223%
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial (Ad)

A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for Phase 2 trials in progressive multiple sclerosis. Unlike existing treatments that suppress the immune system, Lucid-MS is designed to protect myelin. In pre-clinical models, it led to movement recovery including walking. Independent research projects peak annual sales up to 5 billion dollars, yet shares still trade under 5 dollars.tc pixel

Learn why this FDA milestone could be a turning point for investors
2/11/2026ARK Investment Management LLC1,985,986$10.43M0.1%+1.6%5.488%
2/11/2026 Deutsche Bank AG18,429$97K0.0%+3,351.1%0.051%
2/11/2026Amova Asset Management Americas Inc.288,081$1.51M0.0%-9.5%0.796%
2/10/2026Goldman Sachs Group Inc.199,286$1.05M0.0%+150.1%0.551%
2/10/2026 AXQ Capital LP28,125$148K0.0%+115.6%0.078%
2/10/2026Intech Investment Management LLC11,515$60K0.0%-13.0%0.032%
2/9/2026Geode Capital Management LLC688,566$3.62M0.0%+2.5%1.902%
2/6/2026 Legato Capital Management LLC155,594$817K0.1%+9.5%0.430%
2/6/2026Nano Cap New Millennium Growth Fund L P120,000$630K0.5%N/A0.332%
2/6/2026 Prescott Group Capital Management L.L.C.361,595$1.90M0.2%+90.3%0.999%
2/5/2026HighMark Wealth Management LLC241,000$1.27M0.5%N/A0.666%
2/4/2026 First Eagle Investment Management LLC623,883$3.28M0.0%+3.3%1.724%
2/4/202649 Wealth Management LLC17,581$92K0.0%-8.4%0.049%
2/3/2026 Mitsubishi UFJ Asset Management Co. Ltd.140,503$715K0.0%-30.5%0.388%
2/2/2026 Strs Ohio29,700$156K0.0%+130.2%0.082%
1/29/2026 Concurrent Investment Advisors LLC11,745$62K0.0%-50.0%0.032%
1/23/2026 Sumitomo Mitsui Trust Group Inc.288,081$1.51M0.0%-9.5%0.796%
1/1/2026JPMorgan Chase & Co.11,238$98K0.0%-15.2%0.031%
11/19/2025GM Advisory Group LLC678,086$5.94M0.3%-41.8%1.874%
11/17/2025Susquehanna International Group LLP23,778$208K0.0%-45.4%0.066%
11/17/2025Millennium Management LLC31,063$272K0.0%-62.4%0.086%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,700$111K0.0%-15.2%0.035%
11/17/2025Granahan Investment Management LLC64,338$564K0.0%N/A0.178%
11/17/2025First Light Asset Management LLC2,510,496$21.99M2.1%+135.2%6.937%
11/17/2025Brevan Howard Capital Management LP11,600$102K0.0%N/A0.032%
11/17/2025Bank of America Corp DE270,069$2.37M0.0%-25.6%0.746%
11/17/2025Alliancebernstein L.P.45,850$402K0.0%-17.8%0.127%
11/14/2025Schonfeld Strategic Advisors LLC103,025$902K0.0%-56.4%0.285%
11/14/2025Raymond James Financial Inc.183,282$1.61M0.0%+2,649.5%0.506%
11/14/2025Brooklyn Investment Group65,631$575K0.0%N/A0.181%
11/14/2025Squarepoint Ops LLC133,774$1.17M0.0%N/A0.370%
11/13/2025BNP Paribas Financial Markets5,374$47K0.0%-74.8%0.015%
11/13/2025FourThought Financial Partners LLC37,334$327K0.0%N/A0.103%
11/13/2025 Russell Investments Group Ltd.10,640$93K0.0%N/A0.029%
11/12/2025Amova Asset Management Americas Inc.318,350$2.79M0.0%-19.3%0.888%
11/12/2025ARK Investment Management LLC1,953,772$17.12M0.1%-26.2%5.448%
11/12/2025Dimensional Fund Advisors LP324,788$2.84M0.0%-10.5%0.906%
11/12/2025Cresset Asset Management LLC16,100$141K0.0%+37.1%0.045%
11/12/2025 First Eagle Investment Management LLC603,962$5.29M0.0%+125.9%1.684%
11/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.202,175$1.77M0.0%-4.9%0.564%
11/12/2025Intech Investment Management LLC13,236$116K0.0%-23.0%0.037%
11/10/2025 AXQ Capital LP13,045$114K0.0%N/A0.036%
11/7/2025Cassaday & Co Wealth Management LLC71,629$627K0.0%N/A0.200%
11/7/2025Vanguard Group Inc.1,421,732$12.45M0.0%-0.7%3.965%
11/7/2025JPMorgan Chase & Co.11,238$98K0.0%-15.2%0.031%
11/6/2025 Essex Investment Management Co. LLC493,949$4.33M0.7%+3.5%1.377%
11/5/2025 IQ EQ FUND MANAGEMENT IRELAND Ltd52,787$462K0.0%+38.2%0.147%
10/30/2025 Strs Ohio12,900$113K0.0%N/A0.036%
10/28/2025 Campbell & CO Investment Adviser LLC66,481$582K0.0%-38.8%0.185%
10/27/2025 Sumitomo Mitsui Trust Group Inc.318,350$2.79M0.0%-20.1%0.888%
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial (Ad)

A NASDAQ-listed biotech just cleared a major FDA milestone. Its lead therapy, Lucid-MS, has been cleared for Phase 2 trials in progressive multiple sclerosis. Unlike existing treatments that suppress the immune system, Lucid-MS is designed to protect myelin. In pre-clinical models, it led to movement recovery including walking. Independent research projects peak annual sales up to 5 billion dollars, yet shares still trade under 5 dollars.tc pixel

Learn why this FDA milestone could be a turning point for investors
10/23/2025 SG Americas Securities LLC17,651$155K0.0%-26.0%0.049%
10/14/2025 Farther Finance Advisors LLC3,233$28K0.0%N/A0.009%
10/6/2025 Old Port Advisors38,629$338K0.1%-47.5%0.108%
8/16/2025Nikko Asset Management Americas Inc.394,375$2.81M0.0%-4.4%1.100%
8/15/2025Manatuck Hill Partners LLC80,000$570K0.2%N/A0.223%
8/15/2025BNP Paribas Financial Markets21,290$152K0.0%-12.1%0.059%
8/15/2025Bank of America Corp DE363,217$2.59M0.0%+221.7%1.013%
8/14/2025First Light Asset Management LLC1,067,613$7.61M1.0%-37.2%2.977%
8/14/2025Jane Street Group LLC47,850$341K0.0%N/A0.133%
8/14/2025Raymond James Financial Inc.6,666$48K0.0%N/A0.019%


MASS Institutional Ownership - Frequently Asked Questions

During the previous two years, 105 institutional investors and hedge funds held shares of 908 Devices. The most heavily invested institutionals were First Light Asset Management LLC ($37.16M), AWM Investment Company Inc. ($23.30M), BlackRock Inc. ($16.92M), Vanguard Group Inc. ($12.45M), ARK Investment Management LLC ($10.43M), Granahan Investment Management LLC ($4.25M), and Needham Investment Management LLC ($4.04M).Learn more on 908 Devices' institutional investors.

88.06% of 908 Devices' stock is owned by institutional investors. Learn more on MASS's institutional investor holdings.

Of the 89 institutional investors that purchased 908 Devices' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: First Light Asset Management LLC ($6.71M), AWM Investment Company Inc. ($3.63M), BlackRock Inc. ($1.94M), GM Advisory Group LLC ($1.17M), Needham Investment Management LLC ($698K), Granahan Investment Management LLC ($695.07K), and Invesco Ltd. ($649.63K).

Institutional investors have bought a total of 13,205,615 shares in the last 24 months. This purchase volume represents approximately $91.11M in transactions.

Of the 29 institutional investors that sold 908 Devices' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($1.70M), GM Advisory Group LLC ($927.07K), ARK Investment Management LLC ($694.51K), First Light Asset Management LLC ($633.48K), Invesco Ltd. ($556.73K), Marshall Wace LLP ($249.00K), and Dimensional Fund Advisors LP ($244.26K).

Institutional investors have sold a total of 5,833,885 shares in the last 24 months. This volume of shares sold represents approximately $39.45M in transactions.



Institutional ownership data for NASDAQ:MASS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/7/2026. New 13F filings are added each quarter as they're published.
From Our Partners